Perspective Therapeutics (CATX) Revenue & Revenue Breakdown
Perspective Therapeutics Revenue Highlights
Latest Revenue (Y)
$1.43M
Latest Revenue (Q)
$234.00K
Perspective Therapeutics Revenue by Period
Perspective Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.43M | -79.81% |
| 2022-12-31 | $7.10M | -34.19% |
| 2022-06-30 | $10.79M | 7.38% |
| 2021-06-30 | $10.05M | 3.85% |
| 2020-06-30 | $9.68M | 32.35% |
| 2019-06-30 | $7.31M | 23.48% |
| 2018-06-30 | $5.92M | 24.41% |
| 2017-06-30 | $4.76M | -0.17% |
| 2016-06-30 | $4.77M | 3.53% |
| 2015-06-30 | $4.61M | 9.18% |
| 2014-06-30 | $4.22M | -6.76% |
| 2013-06-30 | $4.53M | -10.76% |
| 2012-06-30 | $5.07M | -3.20% |
| 2011-06-30 | $5.24M | -0.89% |
| 2010-06-30 | $5.29M | -2.43% |
| 2009-06-30 | $5.42M | -24.32% |
| 2008-06-30 | $7.16M | 24.76% |
| 2007-06-30 | $5.74M | 187.72% |
| 2006-06-30 | $1.99M | 888.60% |
| 2005-06-30 | $201.73K | 100.00% |
| 2004-09-30 | - | 100.00% |
| 2003-09-30 | - | 100.00% |
| 2002-09-30 | - | 100.00% |
| 2001-09-30 | - | 100.00% |
| 2000-09-30 | - | 100.00% |
| 1999-09-30 | - | 100.00% |
| 1998-09-30 | - | -100.00% |
| 1997-09-30 | $7.85M | -4.96% |
| 1996-09-30 | $8.26M | 5.64% |
| 1995-09-30 | $7.82M | 15.16% |
| 1994-09-30 | $6.79M | - |
Perspective Therapeutics generated $1.43M in revenue during NA 2023, up -79.81% compared to the previous quarter, and up 19.61% compared to the same period a year ago.
Perspective Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $234.00K | -31.58% |
| 2025-03-31 | $342.00K | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $337.00K | -82.35% |
| 2023-09-30 | $1.91M | 27.27% |
| 2023-06-30 | $1.50M | -18.03% |
| 2023-03-31 | $1.83M | -0.27% |
| 2022-12-31 | $1.83M | 6.87% |
| 2022-09-30 | $1.72M | -31.46% |
| 2022-06-30 | $2.50M | -13.92% |
| 2022-03-31 | $2.91M | 3.34% |
| 2021-12-31 | $2.82M | 9.83% |
| 2021-09-30 | $2.56M | -5.39% |
| 2021-06-30 | $2.71M | 4.23% |
| 2021-03-31 | $2.60M | 10.22% |
| 2020-12-31 | $2.36M | -1.05% |
| 2020-09-30 | $2.38M | 4.61% |
| 2020-06-30 | $2.28M | -20.87% |
| 2020-03-31 | $2.88M | 30.55% |
| 2019-12-31 | $2.21M | -4.71% |
| 2019-09-30 | $2.31M | 20.32% |
| 2019-06-30 | $1.92M | - |
| 2019-03-31 | $1.92M | 1.05% |
| 2018-12-31 | $1.90M | 21.90% |
| 2018-09-30 | $1.56M | -2.56% |
| 2018-06-30 | $1.60M | 1.91% |
| 2018-03-31 | $1.57M | 2.41% |
| 2017-12-31 | $1.54M | 26.84% |
| 2017-09-30 | $1.21M | -11.61% |
| 2017-06-30 | $1.37M | 6.86% |
| 2017-03-31 | $1.28M | 24.71% |
| 2016-12-31 | $1.03M | -4.90% |
| 2016-09-30 | $1.08M | -3.50% |
| 2016-06-30 | $1.12M | -6.55% |
| 2016-03-31 | $1.20M | 12.49% |
| 2014-12-31 | $1.07M | 2.25% |
| 2014-09-30 | $1.04M | 9.75% |
| 2014-06-30 | $949.52K | -16.29% |
| 2014-03-31 | $1.13M | 4.51% |
| 2013-12-31 | $1.09M | 3.38% |
| 2013-09-30 | $1.05M | -15.47% |
| 2013-06-30 | $1.24M | -0.75% |
| 2013-03-31 | $1.25M | 28.30% |
| 2012-12-31 | $975.46K | -7.65% |
| 2012-09-30 | $1.06M | -19.47% |
| 2012-06-30 | $1.31M | -0.43% |
| 2012-03-31 | $1.32M | 7.22% |
| 2011-12-31 | $1.23M | 1.26% |
| 2011-09-30 | $1.21M | -3.41% |
| 2011-06-30 | $1.26M | -10.95% |
| 2011-03-31 | $1.41M | 13.32% |
| 2010-12-31 | $1.24M | -6.19% |
| 2010-09-30 | $1.33M | -0.62% |
| 2010-06-30 | $1.34M | 10.99% |
| 2010-03-31 | $1.20M | -12.07% |
| 2009-12-31 | $1.37M | -0.78% |
| 2009-09-30 | $1.38M | 14.42% |
| 2009-06-30 | $1.21M | -11.79% |
| 2009-03-31 | $1.37M | 2.98% |
| 2008-12-31 | $1.33M | -12.69% |
| 2008-09-30 | $1.52M | - |
Perspective Therapeutics generated $234.00K in revenue during Q2 2025, up -31.58% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Perspective Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| STIM | Neuronetics | $74.89M | $37.30M |
| MXCT | MaxCyte | $38.63M | $10.39M |
| TLSI | TriSalus Life Sciences | $29.43M | $11.21M |
| IVVD | Invivyd | $25.38M | $13.13M |
| PROF | Profound Medical | $10.68M | $2.62M |
| NNOX | Nano-X Imaging | $9.90M | $2.55M |
| NYXH | Nyxoah | $4.30M | $1.22M |
| AVR | Anteris Technologies Global | $2.73M | $556.00K |
| CATX | Perspective Therapeutics | $1.43M | $234.00K |
| HSDT | Solana | $520.00K | $49.00K |